Skip to main content

Anti-Aging Research: Science, not Hype

Last updated November 2021
Q: "How is aging a disease?"

A: "It's a dynamic system that veers away from its homeostasis (normal equilibrium point): hence a form of slow-progressing illness. Labeling it as 'natural' is a surrender to our traditional state of ignorance and powerlessness, which fortunately is beginning to be changed!"
The above is my standard answer to an oft-asked question.

The science of aging is by all evidence very misunderstood by the general public.  Hype, misinformation and unquestioned assumptions often prevail, unfortunately.

Aging as a systemic breakdown of the body, rather than a series of isolated events and conditions.

This 2013 diagram from NIH is a good way to jump-start contemplating the big picture:

The diagram originates from the Cell journal: The Hallmarks of Aging  

Telomere shortening is perhaps the one most talked about - but just one of several processes.  As stated in the above paper:
Each hallmark should ideally fulfill the following criteria:
(1) it should manifest during normal aging;
(2) its experimental aggravation should accelerate aging; and
(3) its experimental amelioration should retard the normal aging process and hence increase healthy lifespan. This set of ideal requisites is met to varying degrees by the proposed hallmarks

The Business Side

That was a little science background for starters - but how about financial/business considerations?

Here’s a fascinating story story about a brilliant 23 y.o. woman, Laura Deming, an MIT graduate who raised $22 million in 2017!  She formed  Longevity Fund, an early-stage venture capital company currently managing $37 millions to invest in anti-aging companies.

Fortunately, both academic researchers and companies are beginning to advance the relatively new field of anti-aging as a subject of systematic scientific pursuit, the "project Apollo" of our times.

You might have heard about the $300 M invested in Unity Biotechnology; the investors include Jeff Bezos (Amazon) and Peter Thiel (Paypal's co-founder.)

Also in recent news was the growing hub of anti-aging startups in the Boston area.  And not just Boston; the longevity companies in the San Francisco area, too, among other places.  In particular, Calico, Google's research on aging and age-related diseases, founded in 2013.  Forbes magazine, in a March 2019 article, reviews opportunities for biotech companies in the Anti-Aging market.

Explosive growth in many directions: even crowdfunding of age-related research.

Anti-aging science is well aligned with my personal research interest in Systems Biology, and in particular Interactomics: I expand on Interactomics and the future of medicine in a separate blog entry

Who's Who in the Anti-Aging Field?

(Alphabetic listing.  Many more entries will be progressively added as I review them.)

AgeX Therapeutics, San Francisco area, CA
Development and commercialization of novel therapeutics targeting human aging.  Its VP of New Technology Discovery is the iconic Aubrey de Grey (a name synonymous with Anti-Aging research and advocacy.)

BioAge, San Francisco area, CA
Working on a broad pipeline of therapies to extend human healthspan and lifespan

Buck Institute for Research on Aging, Novato, CA.
The world’s first biomedical research institution devoted solely to research on aging.  In operation since 1999, it has a fairly large faculty in its own sizable campus a little north of San Francisco.  They follow many directions, and their website mentions 10 focus areas.

Calico Life Sciences,  South San Francisco, CA
Google's research on aging and age-related diseases, founded in 2013.  In an extended collaboration with the Broad Institute (MIT and Harvard.)

Celularity, Florham Park, NJ
It has demonstrated that placental-derived stem cells given to animals can extend life up to 30 percent. Celularity now aims to make this approach viable in humans. (Source: blog entry from the company's co-founder Peter Diamandis, the founder of the well-known XPRIZE Foundation.)

FightAging.org, something of an information clearinghouse on anti-aging research.

Human Longevity, San Diego, CA
Genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy human lifespan 

InSilico Medicine, Hong Kong (also with a strong Russian collaboration.)
AI for drug discovery, biomarker development & aging research.  They sponsor the Aging Research & Drug Discovery meetings.

Juvena Therapeutics,  Palo Alto, CA
Biopharma startup developing protein-based tissue rejuvenation.

Juvenescence, San Diego, CA
Developing therapies to treat diseases of aging and increase human longevity.  Their website has a good timeline of the major breakthroughs in aging research

Lifespan.io (LEAF) New York City, NY
Life Extension Advocacy Foundation. A non-profit involved in fundraising, science journalism and running the annual conference Ending Age-Related Diseases.

MDI Biological Laboratory, Salisbury Cove, ME
Non-profit biomedical research institution with a research program in regenerative and aging biology and medicine.

OpenCures, Novato, CA and Alberta, Canada
Dec. 2020 update: I worked here as the CTO between June and Nov. 2020, before relocating to GSK.  During my tenure, the company started making use of the game-changing technology of graph databases, which I discuss in this entry.
A start-up focused on using community research and individuals’ health data to discover and develop interventions in age-related disease.  Started by the co-founder of the SENS Research Foundation, Kevin Perrott.  A main focus is metabolomics - involving the measurements of a large number of biomarkers carried out by Prodrome Sciences.

Regenerative Medicine Foundation, Wellington, FL
Conferences, Patient Advocacy, Policy, Outreach and Networking

SENS Research Foundation, Mountain View, CA
A non-profit supporting
 research projects at universities and institutes, with a focus on a damage-repair paradigm for treating the diseases of aging.  It co-sponsors the large annual international conference "Undoing Aging", and was co-founded in 2009 by Aubrey de Grey.

Termis : Tissue Engineering and Regenerative Medicine International Society 

A very international nonprofit founded in 2006 

UNITY Biotechnology, South San Francisco, CA
Their initial focus is on creating "senolytic" medicines to selectively eliminate senescent cells and hopefully treat age-related diseases.
Investors include Jeff Bezos (Amazon) and Peter Thiel (Paypal's co-founder.)

Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina
It has been engineering laboratory-grown organs that were successfully implanted into humans.

Additional entries (142 companies as of Apr. 2021) in this spreadsheet from AgingBiotech.info


Other News Sources

Longevity Technology


Events

[JULY 2021 UPDATE]  Covid forced all event to go online, and ironically it made infinitely easier to attend international conferences...  Over the past year, I've enjoined attending several international conferences in Longevity Science.  
I've been blown away by the galloping pace of recent developments, and the rapid-fire formation of startups to explore promising directions.
Here are some conferences that I attended myself, or that I know of:

Aging Research & Drug Discovery meetings.  Sponsored by InSilico Medicine.

American Aging Association meetings.  Annual.  In its 49th year as of the next meeting.

BAAM: Bay Area Aging Meetings.  Twice/year.  Hosted by UC Berkeley, Stanford, UCSF, Buck Institute for Research on Aging, and the Gladstone Institutes.

Ending Age-Related Diseases.  Sponsored by Lifespan.io
I attended the latest one (
Aug. 2020), and was impressed:  I will be reporting details in future blog entries.

Metabesity.   " ‘Metabesity’ is a term coined by G Alexander Fleming MD to reference the constellation of interconnected diseases with metabolic roots. Targeting these metabolic underpinnings could be a productive approach to delaying, or even preventing, many or most of the chronic diseases of aging." (source)
I attended the latest one (Oct. 2020): another fine conference!

Undoing Aging.  Large annual international conference.

Additional entries in this spreadsheet from AgingBiotech.info 


On Social Media

My professional/scientific profile on Facebook

 

Facebook pages by organizations: 

Open Cures  (I worked here in 2020)

SENS Research Foundation

 

Facebook groups:

Ending aging: SENS, SENS Foundation, Aubrey de Grey
Informal community discussion of the work of Aubrey de Grey and SENS Research Foundation (SRF)

 

Review of Facebook groups:

10 Best Longevity Facebook Groups


Venture Funds

fightaging.org lists the following Venture Funds:

Other Funding Sources

Comments

Popular posts from this blog

Online Courses: (Often) Free and Just Awesome!

“Education is the kindling of a flame, not the filling of a vessel.” -Socrates.  [UPDATED Mar. 2021] Acquiring knowledge has been a hobby of mine since 4th grade, so it's no surprise that I'm the proverbial "kid in the candy store" when it comes to online courses!   As of writing, I have followed over 20 so far, and trying to decide what the next one will be... Utopia or Dystopia? You ever find yourself imagining the future, and wondering whether it'll turn out to be “utopian” or “dystopian”? Well, the state of higher education in the United States is decisively dystopian , with its absurdly ballooned costs and runaway student loans (a “bubble” that may burst sooner or later, mark my words!),  BUT there’s a counterpoint that is decisively utopian , namely the explosive rise of free online courses 😊 Here’s a brief 2012 Ted talk about the rise of free online courses , dated but still of interest. The gist of that TED talk is that online learning has com

Graph Databases (Neo4j) - a revolution in modeling the real world!

(UPDATED 9/2022) - I was "married" to Relational Databases for many years... and it was a good "relationship" full of love and productivity - but SOMETHING WAS MISSING! Let me backtrack.   In college, I got a hint of the "pre-relational database" days...  Mercifully, that was largely before my time, but  - primarily through a class - I got a taste of what the world was like before relational databases.  It's an understatement to say: YUCK! Gratitude for the power and convenience of Relational Databases and SQL - and relief at having narrowly averted life before it! - made me an instant mega-fan of that technology.  And for many years I held various jobs that, directly or indirectly, made use of MySQL and other relational databases - whether as a Database Administrator, Full-Stack Developer, Data Scientist, CTO or various other roles. But there were thorns in the otherwise happy relationship The root cause: THE REAL WORLD DOES NOT REALLY RESEMBLE THE

D3 Visualization with Vue.js : a powerful alliance (when done right!)

[UPDATED MAY 2022]  D3.js is a very powerful visualization tool, especially for specialized/custom needs...  On the flip side, it's rather hard to use - with a steep learning curve. Even worse if one also wants interactivity ! But why is D3 so hard/clunky to use?  And what can be done about it? Spoiler alert: Vue.js (or other modern front-end framework) to the rescue - if done right... All code in the examples is available in this GitHub repository . The Root of the Problem In a nutshell, what makes D3 awkward to use is that, for historical reasons, it tries to do too much : most painfully, it uses an old way to do direct DOM manipulation (i.e. restructuring the page layout) - an operation that nowadays is superbly handled in a far more friendly way by modern front-end frameworks, such as Vue.js Document Object Model ( DOM ) is a programming interface for web documents.  In simple terms, it's the structure of the elements on a web page (text, images, etc.) Let the front-e

A "Seismic Shift" in Longevity Science : Mainstream Acceptance + Large Funding

"You are incredibly prescient!"   I woke up to those words from a former colleague on Jan. 19, 2022: the bombshell announcement that the Chief Science Officer of pharma giant GSK, where I worked until recently, will become the CEO at the new, $3 BILLION longevity science company Altos (presumably also funded by Amazon's Jeff Bezos.) Big Pharma is at long last embracing Longevity Science. The corollary: longevity science is entering Mainstream (with capital "M") But let me backtrack... The Decade of Longevity Science When Harvard professor David Sinclair declared the 2020's to be the " decade of the paradigm shift about age reversal ", one could perhaps be dismissive of it as just an outburst of enthusiasm... But in the past couple of years, we're seeing strong evidence that his forecast is right on the mark! While I worked at GlaxoSmithKline - a giant, top-10, pharma company - I vigorously advocated forming a Longevity Science dept., and sp

Life123 : Quantitative Modeling of Biological Systems

(UPDATED 8/2022) - Are we ready to embark on a next-generation detailed quantitative modeling of complex biological systems , including whole-cell simulations?  An anticipated up-jump in computing power may be imminent from Photonics computers (which I discuss here ), and GPU's are rapidly gaining power as well...  Are we in ready state to put existing - and upcoming - power to good use? This is a manifest, and a call to action What's Life123? It's about detailed quantitative modeling of biological systems in 1-D, 2-D and full 3-D, as well as a multi-faceted software platform for doing so. What's (pseudo-)1D?  For now, let's say it's like the inside of a long, thin tube - with no interactions with the tube.  Likewise, (pseudo-)2D can be thought of as a Petri dish, with no interactions with the lid or the bottom. Website : https://life123.science A purposeful decision to also utilize 1D and 2D But why?  Yes, it's in part about "walk before you run&quo

Multimedia Knowledge Representation and Management : "Brain Annex"

 (Updated Feb. 2022) Wouldn't it be fantastic to have a "butler" to help us as we constantly face drowning in information? That need was crushingly pressing for me , as a polymath with a thirst for knowledge in several fields, not to mention numerous very technical jobs over the years, several complex research projects, old notes from college and grad school, an endless stream of online courses I take , a tech startup I founded and used to run, the many conferences I attend, life in general, and even hobbies that tend to generate abundant information (such as flying airplanes and studying multiple foreign languages!)   I was immensely eager for some sort of powerful assistance, something so helpful that I could poetically describe as an " annex " to my brain.. In this blog entry, I'll describe how deep frustration with existing software tools led to the start of the open-source BrainAnnex.org project, a web-based knowledge representation and manageme

Interactomics + Super (or Quantum) Computers + Machine Learning : the Future of Medicine?

[Updated Mar. 2021] Interactomics today bears a certain resemblance to genomics in the  1990s...  Big gaps in knowledge, but an explosively-growing field of great promise. If you're unfamiliar with the terms, genomics is about deciphering the gene sequence of an organism, while interactomics is about describing all the relevant bio-molecules and their web of interactions. A Detective Story Think of a good police-detective story; typically there is a multitude of characters, and an impossible-to-remember number of relationships: A hates B, who loves C, who had a crush on D, who always steers clear of E, who was best friends with A until D arrived... Yes, just like those detective stories, things get very complex with our biological story!  Examples of webs of interactions, familiar to many who took intro biology, are the Krebs cycle for metabolism or the Calvin cycle to fix carbon into sugars in plant photosynthesis. Now, imagine vastly expanding those cycles of rea

Brain Microarchitecture : Feedback from Higher-order areas to Lower-order areas

Some questions that arise in Machine Learning involve the prospect of using feedback from Higher-order areas (downstream) to Lower-order areas (upstream), and using Global Knowledge for Local Processing.  A desire to gain insight into those issues from Neuroscience ("how does the brain do it?") led me to some fascinating investigations into the Microcircuits of the Cerebral Cortex.  This blog entry is a broad review of the field, in the context of the original motivating questions from Machine Learning.   Starting out with a quote from the “bible of Neuroscience”: From Principles of Neural Science, 5th edn  (Online book location 1435.3 / 5867).  Emphasis and note added by me: Sensory pathways are not exclusively serial; in each functional pathway higher-order areas project back to the lower-order areas from which they receive input. In this way neurons in higher-order areas, sensitive to the global pattern of sensory input, can modulate the activity of neurons in lowe

Photonic Computer - a "supercharged GPU" with very low energy consumption

Yes, we all wish for Quantum Computers... but in the meantime we need something here and now!  Could Photonic Computers fit that role? Just about everyone has heard of fiber optics – using light for data transmission – but did you know that light can also be used for computing? There's a new commercial product expected for early next year (2022) . I contacted the CEO, Nicholas Harris, of a 4-y.o. startup, Lightmatter , interviewed in April 2021 here . Photonic computers, at least in their first commercial appearance, are essentially accelerator cards for Linear Algebra - and so of special interest for Machine Learning and some types of simulations.    Their claims are remarkable: 10X faster than some of the best GPUs using 90% less energy can be used with existing software stacks, such as TensorFlow commercially available early next year (2022) a lot of future growth, as additional wavelengths of light get used in parallel My own interest is pr